Literature DB >> 19219407

Acute myocardial infarction following oral methyl-ergometrine intake.

Axel de Labriolle1, Olivier Genée, Laurens Mitchell Heggs, Laurent Fauchier.   

Abstract

Ergot derivatives are frequently administrated during cesarean delivery, induced abortion, or post-partum hemorrhage to promote uterine contractions. Ergot derivatives may also induce coronary spasm and intravenous ergonovine is used in cardiac catheterization laboratories as a diagnostic agent. Serious ischemic cardiac events related to ergonovine are rare and have most often been described after intravenous use. We report the case of a 38-year-old woman with a ST elevation myocardial infarction (STEMI) few days after artificially induced abortion by oral prescription of methylergometrine. Coronary angiography performed 2 days after onset of chest pain did not reveal any abnormalities of the coronary arteries but a provocative test using intravenous methylergometrine was positive with reproduction of chest pain, ECG changes and with a significant narrowing localized on the second segment of the left anterior descending artery at the angiogram. Thus, since methylergometrin may clearly induce coronary spasm when prescribed orally, chest pain occurring under oral treatment should require immediate attention even if atypical or in the absence of cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219407     DOI: 10.1007/s12012-009-9031-9

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  7 in total

1.  Cardiac arrest with pulmonary edema in a non-parturient after ergonovine administration recovered with extracorporeal membrane oxygenation -A case report-.

Authors:  Han Sook Lee; Ji Young Min; Yoonki Lee
Journal:  Korean J Anesthesiol       Date:  2012-12-14

2.  Methylergonovine maleate and the risk of myocardial ischemia and infarction.

Authors:  Brian T Bateman; Krista F Huybrechts; Sonia Hernandez-Diaz; Jun Liu; Jeffrey L Ecker; Jerry Avorn
Journal:  Am J Obstet Gynecol       Date:  2013-07-11       Impact factor: 8.661

3.  Reversible cerebral vasoconstriction syndrome with limb myoclonus following intravenous administration of methylergometrine.

Authors:  Tomoko Ishibashi; Satoru Ishibashi; Tokujiro Uchida; Koichi Nakazawa; Koshi Makita
Journal:  J Anesth       Date:  2011-03-23       Impact factor: 2.078

4.  Ischemic colitis secondary to ergotamine use: a case study.

Authors:  Regina E Rodman; Thomas D Willson; Mark M Connolly; Francis J Podbielski
Journal:  Case Rep Gastroenterol       Date:  2011-01-05

5.  Transient sick sinus syndrome with complete atrioventricular block associated with ergonovine intake: A case report.

Authors:  Hui-Ting Wang; Wen-Hao Liu; Yung-Lung Chen
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

6.  Methylergometrine-Induced Myocardial Infarction in the Setting of a Cesarean Delivery.

Authors:  Mohamed Fayed; Branden Buffington; Rowaa Ibrahim; Ami Y Attali; Joshua Younger
Journal:  Cureus       Date:  2021-12-01

7.  Ergometrine for postpartum hemorrhage and associated myocardial ischemia: Two case reports and a review of the literature.

Authors:  Stuart P E Spencer; Sandra A Lowe
Journal:  Clin Case Rep       Date:  2019-11-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.